User profiles for Nigel Temperton

Nigel Temperton

Professor of Molecular Virology
Verified email at kent.ac.uk
Cited by 14442

[HTML][HTML] Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

…, JM Jimenez-Guardeño, MJ Lista, N Temperton… - Nature …, 2020 - nature.com
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

[PDF][PDF] Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum

…, B Constantinides, H Webster, N Temperton… - Cell, 2022 - cell.com
The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread
rapidly to become globally dominant and has split into a number of sublineages. BA.1 …

[PDF][PDF] Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum

…, MM Siqueira, C Dold, N Temperton… - Cell, 2021 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone progressive
change, with variants conferring advantage rapidly becoming dominant lineages, eg, B.…

[HTML][HTML] SARS-CoV-2 evolution during treatment of chronic infection

, … and software & analysis tools Temperton Ben 87 Roy … - Nature, 2021 - nature.com
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

…, L Calder, F Sallusto, P Collins, LF Haire, N Temperton… - Science, 2011 - science.org
The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought
goal for therapeutic approaches and vaccine design. Using a single-cell culture …

Immune boosting by B. 1.1. 529 (Omicron) depends on previous SARS-CoV-2 exposure

…, M Sugimoto, L Swadling, S Taylor, N Temperton… - Science, 2022 - science.org
The Omicron, or Pango lineage B.1.1.529, variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …

[HTML][HTML] Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes

NJ Temperton, PK Chan, G Simmons… - Emerging infectious …, 2005 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome–associated coronavirus (SARS-CoV) spike protein (S)
is a major target for neutralizing antibodies. Retroviral SARS-CoV S pseudotypes have …

T cell responses to whole SARS coronavirus in humans

…, L Wang, M Zhang, X Tang, NJ Temperton… - The Journal of …, 2008 - journals.aai.org
Effective vaccines should confer long-term protection against future outbreaks of severe acute
respiratory syndrome (SARS) caused by a novel zoonotic coronavirus (SARS-CoV) with …

[HTML][HTML] Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

…, FJ Torres-Velez, NJ Temperton… - The Journal of …, 2010 - Am Soc Clin Investig
The target of neutralizing antibodies that protect against influenza virus infection is the viral
protein HA. Genetic and antigenic variation in HA has been used to classify influenza viruses …

[PDF][PDF] Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

…, B Constantinides, H Webster, N Temperton… - Cell, 2022 - cell.com
Highly transmissible Omicron variants of SARS-CoV-2 currently dominate globally. Here,
we compare neutralization of Omicron BA.1, BA.1.1, and BA.2. BA.2 RBD has slightly higher …